BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 18576257)

  • 21. Assessing the case for the regulation of research.
    Wilkinson T
    Am J Bioeth; 2010 Aug; 10(8):63-5. PubMed ID: 20694915
    [No Abstract]   [Full Text] [Related]  

  • 22. Universal and uniform protection of human subjects in research: also a fallacy in some developing countries.
    Outomuro D
    Am J Bioeth; 2008 Nov; 8(11):19-20. PubMed ID: 19061101
    [No Abstract]   [Full Text] [Related]  

  • 23. Risking the rewards of regulation.
    Schwab AP
    Am J Bioeth; 2008 Nov; 8(11):9-10. PubMed ID: 19061096
    [No Abstract]   [Full Text] [Related]  

  • 24. Ethical human-research protections: not universal and not uniform.
    Fleming DA; Reynolds D
    Am J Bioeth; 2008 Nov; 8(11):21-2. PubMed ID: 19061102
    [No Abstract]   [Full Text] [Related]  

  • 25. Is pragmatism just an apology for unrestrained science?
    Spriggs M
    Am J Bioeth; 2008 Apr; 8(4):39-41. PubMed ID: 18576253
    [No Abstract]   [Full Text] [Related]  

  • 26. Civic trust, scientific objectivity, and the publicity condition.
    Potter NN
    Am J Bioeth; 2010 Aug; 10(8):57-8. PubMed ID: 20694911
    [No Abstract]   [Full Text] [Related]  

  • 27. Protecting the vulnerable in brain research.
    Cook-Deegan RM
    Cerebrum; 2000; 2(2):73-91. PubMed ID: 15986545
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human subjects research with prisoners: putting the ethical question in context.
    Obasogie OK; Reiter KA
    Bioethics; 2011 Jan; 25(1):55-6. PubMed ID: 21158873
    [No Abstract]   [Full Text] [Related]  

  • 29. Human experimentation in developing countries: improving international practices by identifying vulnerable populations and allocating fair benefits.
    Farrell K
    J Health Care Law Policy; 2006; 9(1):136-61. PubMed ID: 17165228
    [No Abstract]   [Full Text] [Related]  

  • 30. A taxonomy of value in clinical research.
    Casarett DJ; Karlawish JH; Moreno JD
    IRB; 2002; 24(6):1-6. PubMed ID: 12683394
    [No Abstract]   [Full Text] [Related]  

  • 31. Time to cut regulations that protect only regulators.
    Nature; 2001 Nov; 414(6862):379. PubMed ID: 11719759
    [No Abstract]   [Full Text] [Related]  

  • 32. Has compliance eclipsed ethics? Should we expect serious ethical consideration or give up and admit that regulations are the only hope?
    Dubler N; Barnes M
    Prot Hum Subj; 2005; (12):7-9. PubMed ID: 16317857
    [No Abstract]   [Full Text] [Related]  

  • 33. Research in children.
    Burns JP
    Crit Care Med; 2003 Mar; 31(3 Suppl):S131-6. PubMed ID: 12626958
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conflict of interest in human subjects research.
    Groeger JS; Barnes M
    Crit Care Med; 2003 Mar; 31(3 Suppl):S137-42. PubMed ID: 12626959
    [No Abstract]   [Full Text] [Related]  

  • 35. The bill submitted to the Brazilian Senate for ethical regulation of clinical research is contrary to the interests of research subjects.
    Palácios M; Rego S
    Cad Saude Publica; 2015 Aug; 31(8):1583-5. PubMed ID: 26375638
    [No Abstract]   [Full Text] [Related]  

  • 36. New requirements for vulnerable subjects and IRB membership.
    Maloney DM
    Hum Res Rep; 2000 Oct; 15(10):9. PubMed ID: 11917935
    [No Abstract]   [Full Text] [Related]  

  • 37. Research oversight through new lenses: the consortium to examine clinical research ethics.
    Sugarman J; Eckenwiler LA; Emanuel EJ
    IRB; 2003; 25(1):9-10. PubMed ID: 12833899
    [No Abstract]   [Full Text] [Related]  

  • 38. The research-treatment distinction: a problematic approach for determining which activities should have ethical oversight.
    Kass NE; Faden RR; Goodman SN; Pronovost P; Tunis S; Beauchamp TL
    Hastings Cent Rep; 2013; Spec No():S4-S15. PubMed ID: 23315895
    [No Abstract]   [Full Text] [Related]  

  • 39. Response to open peer commentaries on "Social contexts influence ethical considerations of research".
    Levine RJ; Gordon JB; Mazure CM; Rubin PE; Schaller BR; Young JL
    Am J Bioeth; 2011 May; 11(5):W1-2. PubMed ID: 21534134
    [No Abstract]   [Full Text] [Related]  

  • 40. The role of controversial research in the IRB's risk/benefit analysis.
    Lunstroth J
    Am J Bioeth; 2011 May; 11(5):14-6. PubMed ID: 21534141
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.